Novavax Inc (NVAX)
13.01
-1.39
(-9.65%)
USD |
NASDAQ |
May 17, 16:00
13.10
+0.09
(+0.69%)
After-Hours: 20:00
Novavax Gross Profit (TTM): 424.85M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 424.85M |
December 31, 2023 | 349.69M |
September 30, 2023 | 357.33M |
June 30, 2023 | 627.91M |
March 31, 2023 | 174.11M |
December 31, 2022 | 804.09M |
September 30, 2022 | -28.48M |
June 30, 2022 | -43.35M |
March 31, 2022 | 339.82M |
December 31, 2021 | 197.58M |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | 9.16M |
June 30, 2013 | 8.561M |
March 31, 2013 | 8.647M |
December 31, 2012 | 7.382M |
September 30, 2012 | 7.373M |
June 30, 2012 | 8.264M |
March 31, 2012 | 8.049M |
December 31, 2011 | 7.684M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
-43.35M
Minimum
Jun 2022
804.09M
Maximum
Dec 2022
320.35M
Average
344.76M
Median
Gross Profit (TTM) Benchmarks
Pfizer Inc | 31.64B |
Moderna Inc | 1.086B |
Sensus Healthcare Inc | 19.10M |
Agilent Technologies Inc | 3.405B |
Vaxart Inc | -- |